Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab + CVA21 in Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1
X4P-001 and Pembrolizumab in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)
- Status
- COMPLETED
- Phase
- PHASE1
PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE2
Dose-seeking Study of Pembrolizumab Plus Vemurafenib and Cobimetinib Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Imaging FDG Flare in Melanoma
- Status
- COMPLETED
- Phase
- N/A
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)
- Status
- COMPLETED
- Phase
- PHASE2